Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Use of a Real-Time Alert System to Identify and Re-Engage Lost-to-Care HIV Patients.

Lubelchek RJ, Fritz ML, Finnegan KJ, Trick WE.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e52-5. doi: 10.1097/QAI.0000000000000973. No abstract available.

PMID:
26918542
2.

Assessing the use of HIV surveillance data to help gauge patient retention-in-care.

Lubelchek RJ, Finnegan KJ, Hotton AL, Hazen R, Murphy P, Prachand NG, Benbow N.

J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S25-30. doi: 10.1097/QAI.0000000000000574.

3.

Transmission clustering among newly diagnosed HIV patients in Chicago, 2008 to 2011: using phylogenetics to expand knowledge of regional HIV transmission patterns.

Lubelchek RJ, Hoehnen SC, Hotton AL, Kincaid SL, Barker DE, French AL.

J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):46-54. doi: 10.1097/QAI.0000000000000404.

4.

Scaling up routine HIV testing at specialty clinics: assessing the effectiveness of an academic detailing approach.

Lubelchek RJ, Hotton AL, Taussig D, Amarathithada D, Gonzalez M.

J Acquir Immune Defic Syndr. 2013 Nov 1;64 Suppl 1:S14-9. doi: 10.1097/QAI.0b013e3182a90167.

5.

Can we broaden the applicability of HIV transmission cluster analyses?

Lubelchek RJ, Beavis KG, Gonzalez M, Kendrick SR, Roberts RR, Barker DE.

AIDS. 2012 May 15;26(8):1043-4. doi: 10.1097/QAD.0b013e3283522d81. No abstract available.

6.

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.

Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K; ECHO and THRIVE Study Groups.

J Antimicrob Chemother. 2012 Aug;67(8):2020-8. doi: 10.1093/jac/dks130. Epub 2012 Apr 24.

7.

Routine, rapid HIV testing of medicine service admissions in the emergency department.

Lubelchek RJ, Kroc KA, Levine DL, Beavis KG, Roberts RR.

Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S65-70. doi: 10.1016/j.annemergmed.2011.03.027.

PMID:
21684411
8.

Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.

Huhn GD, Badri S, Vibhakar S, Tverdek F, Crank C, Lubelchek R, Max B, Simon D, Sha B, Adeyemi O, Herrera P, Tenorio A, Kessler H, Barker D.

AIDS Res Ther. 2010 Dec 14;7:44. doi: 10.1186/1742-6405-7-44.

9.

Reliability at the lower limits of HIV-1 RNA quantification in clinical samples: a comparison of RT-PCR versus bDNA assays.

Lubelchek RJ, Max B, Sandusky CJ, Hota B, Barker DE.

PLoS One. 2009 Jun 23;4(6):e6008. doi: 10.1371/journal.pone.0006008.

10.

Strategies for preventing catheter-related bloodstream infections: the role of new technologies.

Lubelchek RJ, Weinstein RA.

Crit Care Med. 2006 Mar;34(3):905-7. No abstract available.

PMID:
16505678
11.

The role of rapid vs conventional human immunodeficiency virus testing for inpatients: effects on quality of care.

Lubelchek R, Kroc K, Hota B, Sharief R, Muppudi U, Pulvirenti J, Weinstein RA.

Arch Intern Med. 2005 Sep 26;165(17):1956-60.

PMID:
16186464

Supplemental Content

Loading ...
Support Center